SYNCOM FORMULATIONS (INDIA)
Back to Income Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹25 Cr | ₹20 Cr | ₹20 Cr | ₹1,053,410 Cr | ₹10 Cr |
What is the latest Consolidated Net Profit of SYNCOM FORMULATIONS (INDIA) ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹25 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹1,053,410 Cr |
| Mar2017 | ₹10 Cr |
How is Consolidated Net Profit of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹25 Cr | 26.12 | |
| Mar2024 | ₹20 Cr | 1.42 | |
| Mar2023 | ₹20 Cr | -100.00 | |
| Mar2022 | ₹1,053,410 Cr | 10,171,878.56 | |
| Mar2017 | ₹10 Cr | - | |
Compare Consolidated Net Profit of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,348.0 Cr | 5.6% | 18.7% | -14.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,937.0 Cr | 1.2% | -7% | 2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,359.0 Cr | 1.8% | 2.7% | 17% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,431.0 Cr | 0.5% | -4.8% | 32.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,114.0 Cr | 0.3% | -4.5% | 11.5% | Stock Analytics | |
| CIPLA | ₹100,028.0 Cr | 0.7% | -5.8% | -13.1% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | 5.6% |
18.7% |
-14.6% |
| SENSEX | 2.4% |
3.2% |
5.8% |
You may also like the below Video Courses